A crucial factor of regenerative healthcare and drug research lies in the ability to expand human stem cell collections to sufficient quantities for therapeutic purposes. Traditionally, constrained cell supply posed a significant barrier to advancement in these fields. Consequently, considerable effort has been directed towards improving methods fo